Figure 4.

Oxygen radical absorbance capacity (ORAC) was analyzed in plasma derived from healthy control subjects (CTR) and FRDA patients before (FRDA) and after two-month (FRDA post-2 months) and one-year (FRDA post-1 year) tocotrienol supplementation. Data are expressed as μM Trolox/L (Mean ± SD). Significance was evaluated by ANOVA (P = 0.0007) and maintained after P value false discovery rate (FDR) correction. Stars show statistical significance for relevant Student’s two-tailed t test comparisons: (*) P < 0.05; (**) P < 0.01.